MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2967/jnumed.126.272085

Медицинская библиотека · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

Thrombotic Microangiopathy in Patients Treated with 177Lu-PSMA Combination Therapies.

Chan Joanna C, Carroll Mitchell T, Hitchen Nadia, Hudson Jo, Kostos Louise K, Puvanakumar Pratheepan, Kranz Sevastjian, Tiong Mark, Au Lewis, Buteau James P, Jackson Price, Azad Arun A, Hofman Michael S, Ruderman Irene, Sandhu Shahneen

СтатьяКлинический случайПеревод в очереди

Аннотация

Over a period of 10 y, our center treated 766 patients with prostate cancer using 177Lu-PSMA (177Lu-PSMA-617 or 177Lu-PSMA I&T). We report 5 cases of 177Lu-PSMA-induced thrombotic microangiopathy (TMA).

Methods

In this retrospective analysis, we reviewed data from all patients at our center who developed histologically confirmed renal TMA after 177Lu-PSMA. Clinical, biochemical, and treatment details were summarized descriptively.

Results

TMA occurred 9-20 mo after initiating 177Lu-PSMA therapy. Four patients had a normal baseline estimated glomerular filtration rate (>90 mL/min/1.73 m2). All patients developed progressive renal impairment with biopsy-proven chronic TMA. Glomerular endothelial PSMA expression was observed in 2 of 3 cases, suggesting a potential on-target mechanism of injury via an increased cumulative organ dose of 177Lu-PSMA. The cumulative renal absorbed dose ranged from 38.6 to 65.3 Gy, and the renal absorbed dose per cycle ranged from 5.4 to 12.4 Gy. Two patients received complement inhibition with eculizumab, which improved hematologic features without meaningful renal recovery.

Conclusion

177Lu-PSMA-associated TMA is a rare but a potentially severe complication of treatment. The contribution of initial versus cumulative renal absorbed dose remains unclear, and early dosimetry may help identify at-risk patients.

Для цитирования: Chan Joanna C, Carroll Mitchell T, Hitchen Nadia, Hudson Jo, Kostos Louise K, Puvanakumar Pratheepan, Kranz Sevastjian, Tiong Mark, Au Lewis, Buteau James P, Jackson Price, Azad Arun A, Hofman Michael S, Ruderman Irene, Sandhu Shahneen. Thrombotic Microangiopathy in Patients Treated with 177Lu-PSMA Combination Therapies.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2026. DOI: 10.2967/jnumed.126.272085.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.